European Hospital & Healthcare Employers’ Association

HOSPEEM Activity Report 2017

The HOSPEEM Activity Report 2017 is published. This activity report presents basic information on the history of HOSPEEM, on the membership structure as well as on the main activities carried out during the year.

2017 has been a productive year with a number of achievements: the start of the new joint HOSPEEM-EPSU project on effective recruitment and retention policies including the June conference “Working together, learning together – Switching to the learning mode”, the start of the HOSPEEM-EPSU new work programme 2017-2019 for the European social dialogue, the high-level metings with European Commissioner Vytenis Andriukaitis and the Bulgarian Minister of Health Prof. Nikolai Petrov, the joint HOSPEEM-HOPE workshop “AMR and workplace learning – The case for a multi-professional approach in hospitals” at the European Parliament.

PDF - 304.4 koDownload the report

 

HOSPEEM-HOPE joint Workshop on AMR & CPD

The European Hospital and Healthcare Federation (HOPE) and the European Hospital and Healthcare Employers' Association (HOSPEEM) organised the following workshop:

HOSPEEM-HOPE joint Workshop on Antimicrobial Resistance and Continuing Professional Development: “AMR and workplace learning-The case for a multi-professional approach in hospitals"
European Parliament, November 22nd, 2017

Agenda and Media release:

Download the Agenda
Download the Media release

Presentations:

 “Prevention and control of AMR in healthcare: raising awareness about best practices” - Dominique Monnet, ECDC, Head of the Disease Programmes on AMR and HAI
“A European One Health action plan on AMR” - Angela Bolufer, European Commission, Member of the AMR Task force
“Collaborating to increase Patient Safety” - Denis Herbaux, CEO, Platform for Continuous Improvement of Quality of Care and Patient Safety (PAQS), Belgium
“The need for cooperation from a One Health perspective against AMR” - Marcel Mennen, Project Manager AMR, National Institute for Public Health and Environment, the Netherlands

This Workshop addressed the importance of continuing professional development for the correct understanding and use of antibiotics by hospital staff and patients and the prevention of infections. Good practice examples to train staff in combatting Antimicrobial Resistance (AMR) in the hospital sector were presented to foster the discussion.

The event also provided the opportunity to emphasize the importance of inter-professional cooperation in combatting AMR. The date chosen for the Workshop  allowed to connect the event to the activities planned for the 2017 European Antibiotic Awareness Day (EAAD) and the launch of the new EAAD Toolkit for Hospital Staff.

The workshop was hosted by MEP Soledad Cabezón Ruiz (Spain, S&D) and took place at the European Parliament, from 15.00 to 17.00 in Room P1C047.

see HOPE Event page 

Twitter#FightAMRinHospitals@euhospitals@HOSPEEM

Photo credits: Mattia Braida, 2017

EFSA/ECDC EU report on antimicrobial resistance

Bacteria found in humans, animals and food continue to show resistance to widely used antimicrobials, according to this report on antimicrobial resistance (AMR) in bacteria published by the European Food Safety Authority (EFSA) and the European Centre for Disease Prevention and Control (ECDC).

Abstract:

The data on antimicrobial resistance in zoonotic and indicator bacteria in 2015, submitted by 28 EU Member States (MSs), were jointly analysed by EFSA and ECDC. Resistance in zoonotic Salmonella and Campylobacter from humans, animals and food, and resistance in indicator Escherichia coli as well as meticillin-resistant Staphylococcus aureus in animals and food were addressed. ‘Microbiological’ resistance was assessed using epidemiological cut-off (ECOFF) values; for some countries, qualitative data on human isolates were interpreted in a way which corresponds closely to the ECOFF-defined ‘microbiological’ resistance. In Salmonella from humans, high proportions of isolates were resistant to ampicillin, sulfonamides and tetracyclines, whereas resistance to third-generation cephalosporins was low. In Salmonella and Escherichia coli isolates from fattening pigs and calves under one year of age, resistance to ampicillin, tetracyclines and sulfonamides was frequently detected, whereas resistance to third-generation cephalosporins was uncommon. For the first time, presumptive extended-spectrum beta-lactamase (ESBL)-/AmpC-/carbapenemase-production in Salmonella and Escherichia coli was monitored in humans (Salmonella), meat (pork and beef), fattening pigs and calves. Varying occurrence/prevalence rates of ESBL-/AmpC-producers were observed between countries, and carbapenemase-producing Escherichia coli were detected in single samples of pig meat and from fattening pigs from two MSs. Resistance to colistin was observed at low levels in Salmonella and Escherichia coli from fattening pigs and calves under one year of age and meat thereof. In Campylobacter from humans, high to extremely high proportions of isolates were resistant to ciprofloxacin and tetracyclines, particularly in C. coli. In a few countries, a third to half of C. coli in humans were resistant also to erythromycin, leaving few options for treatment of severe Campylobacter infections. High resistance to ciprofloxacin and tetracyclines was observed in Ccoli isolates from fattening pigs, whereas much lower levels were recorded for erythromycin. Co-resistance to critically important antimicrobials in both human and animal isolates was generally uncommon.

Read the scientific report (February 2017)